REGISTER
OCC 2026 | Don’t Miss Polyvascular Disease
This roundtable discussed polyvascular disease management amid guideline shortages: Prof. Yi Li advised prioritizing fatal vascular lesions, while Dr. John P. Cooke emphasized early diagnosis and preventive therapy to avoid overlooked peripheral artery disease.


In OCC 2026 Quest for Truth roundtable, leading cardiovascular experts gather to discuss “Pan-Vascular Disease · Integration: From Single Organ to Systemic Management”. The session is hosted by Prof. Gang Wu, Shanghai General Hospital, and Prof. Lingcong Kong, Renji Hospital, Shanghai Jiao Tong University School of Medicine. Quest for Truth is honored to welcome two distinguished guest speakers: Dr. John P. Cooke, Stanford Medicine; and Prof. Yi Li, The First Affiliated Hospital, Sun Yat-sen University.

In this segment, the discussion focuses on clinical decision-making when patients present with complex multivascular disease and formal guidelines do not fully address overlapping conditions. Prof. Gang Wu asks how physicians should navigate guideline gaps when coronary artery disease, peripheral artery disease, cerebrovascular disease, or other vascular conditions coexist in the same patient.

Prof. Yi Li emphasizes a practical principle: treat the most life-threatening condition first. He explains that when vascular diseases share similar treatment strategies, such as antiplatelet and lipid-lowering therapy, management may be straightforward. But when risks conflict, such as hemorrhagic cerebrovascular disease in a patient with a coronary stent, physicians must balance competing priorities and address the most immediate danger before reassessing the overall situation.

Dr. John P. Cooke highlights that the most common error in polyvascular disease is failing to recognize it. He notes that peripheral artery disease is often missed, especially when symptoms such as difficulty walking are attributed to neurologic, joint, or back problems. He stresses that diagnosis must come first, followed by aggressive preventive care, including lipid and diabetes management, walking programs, antiplatelet and antithrombotic therapy, smoking cessation, and other evidence-based interventions that can make a major difference for patients with polyvascular disease.

0
0
Loading